BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yanada M, Yamamoto K, Emi N, Naoe T, Suzuki R, Taji H, Iida H, Shimokawa T, Kohno A, Mizuta S, Maruyama F, Wakita A, Kitaori K, Yano K, Hamaguchi M, Hamajima N, Morishima Y, Kodera Y, Sao H, Morishita Y. Cytomegalovirus antigenemia and outcome of patients treated with pre-emptive ganciclovir: retrospective analysis of 241 consecutive patients undergoing allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2003;32:801-807. [PMID: 14520425 DOI: 10.1038/sj.bmt.1704232] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 El Haddad L, Ghantoji SS, Park AK, Batista MV, Schelfhout J, Hachem J, Lobo Y, Jiang Y, Rondon G, Champlin R, Chemaly RF. Clinical and economic burden of pre-emptive therapy of cytomegalovirus infection in hospitalized allogeneic hematopoietic cell transplant recipients. J Med Virol 2020;92:86-95. [PMID: 31448830 DOI: 10.1002/jmv.25574] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
2 Mori Y, Jinnouchi F, Takenaka K, Aoki T, Kuriyama T, Kadowaki M, Odawara J, Ueno T, Kohno K, Harada T, Yoshimoto G, Takase K, Henzan H, Kato K, Ito Y, Kamimura T, Ohno Y, Ogawa R, Eto T, Nagafuji K, Akashi K, Miyamoto T. Efficacy of prophylactic letermovir for cytomegalovirus reactivation in hematopoietic cell transplantation: a multicenter real-world data. Bone Marrow Transplant 2021;56:853-62. [DOI: 10.1038/s41409-020-01082-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
3 Piñana JL, Martino R, Barba P, Margall N, Roig MC, Valcárcel D, Sierra J, Rabella N. Cytomegalovirus infection and disease after reduced intensity conditioning allogeneic stem cell transplantation: single-centre experience. Bone Marrow Transplant 2010;45:534-42. [DOI: 10.1038/bmt.2009.180] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
4 Barnes S, Schilizzi O, Audsley KM, Newnes HV, Foley B. Deciphering the Immunological Phenomenon of Adaptive Natural Killer (NK) Cells and Cytomegalovirus (CMV). Int J Mol Sci 2020;21:E8864. [PMID: 33238550 DOI: 10.3390/ijms21228864] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
5 Stern L, Withers B, Avdic S, Gottlieb D, Abendroth A, Blyth E, Slobedman B. Human Cytomegalovirus Latency and Reactivation in Allogeneic Hematopoietic Stem Cell Transplant Recipients. Front Microbiol 2019;10:1186. [PMID: 31191499 DOI: 10.3389/fmicb.2019.01186] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 15.0] [Reference Citation Analysis]
6 Patel SR, Ridwan RU, Ortín M. Cytomegalovirus reactivation in pediatric hemopoietic progenitors transplant: a retrospective study on the risk factors and the efficacy of treatment. J Pediatr Hematol Oncol 2005;27:411-5. [PMID: 16096521 DOI: 10.1097/01.mph.0000174242.80167.9d] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
7 Brown JM. Fungal infections in bone marrow transplant patients. Curr Opin Infect Dis 2004;17:347-52. [PMID: 15241080 DOI: 10.1097/01.qco.0000136935.13662.af] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
8 Takenaka K, Nishida T, Asano-Mori Y, Oshima K, Ohashi K, Mori T, Kanamori H, Miyamura K, Kato C, Kobayashi N, Uchida N, Nakamae H, Ichinohe T, Morishima Y, Suzuki R, Yamaguchi T, Fukuda T. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group. Biol Blood Marrow Transplant 2015;21:2008-16. [PMID: 26211985 DOI: 10.1016/j.bbmt.2015.07.019] [Cited by in Crossref: 85] [Cited by in F6Publishing: 87] [Article Influence: 12.1] [Reference Citation Analysis]
9 Kumar M, Roychowdhury M, Kumar J, Harishankar A, Sinha S, Bhave SJ, Chakrapani A, Radhakrishnan V, Nair R, Bhattacharya S, Chandy M. Cytomegalovirus reactivation and disease amongst patients with allogeneic haematopoietic stem cell transplantation in Eastern India: Epidemiology, outcome and healthcare cost. Indian J Med Microbiol 2018;36:49-53. [PMID: 29735826 DOI: 10.4103/ijmm.IJMM_17_269] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Acar K, Akı SZ, Ozkurt ZN, Bozdayı G, Rota S, Türköz Sucak G. Factors associated with cytomegalovirus reactivation following allogeneic hematopoietic stem cell transplantation: human leukocyte antigens might be among the risk factors. Turk J Haematol 2014;31:276-85. [PMID: 25330521 DOI: 10.4274/tjh.2013.0244] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.1] [Reference Citation Analysis]
11 Yokose T, Obara H, Shinoda M, Nakano Y, Kitago M, Yagi H, Abe Y, Yamada Y, Matsubara K, Oshima G, Hori S, Ibuki S, Higashi H, Masuda Y, Hayashi M, Mori T, Kawaida M, Fujimura T, Hoshino K, Kameyama K, Kuroda T, Kitagawa Y. Colon perforation due to antigenemia-negative cytomegalovirus gastroenteritis after liver transplantation: A case report and review of literature. World J Gastroenterol 2019; 25(15): 1899-1906 [PMID: 31057303 DOI: 10.3748/wjg.v25.i15.1899] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Atay D, Erbey F, Akcay A, Dag A, Ozturk G. Oral Valganciclovir as Preemptive Therapy for Cytomegalovirus Reactivation in Pediatric Hematopoietic Stem Cell Transplant Patients. Journal of Pediatric Hematology/Oncology 2015;37:543-7. [DOI: 10.1097/mph.0000000000000397] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
13 Peric Z, Wilson J, Durakovic N, Ostojic A, Desnica L, Vranjes VR, Marekovic I, Serventi-Seiwerth R, Vrhovac R. Early human cytomegalovirus reactivation is associated with lower incidence of relapse of myeloproliferative disorders after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2018;53:1450-6. [PMID: 29662245 DOI: 10.1038/s41409-018-0172-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
14 Torre-Cisneros J, Caston-Osorio JJ, Martín C, Rivero A, Doblas A, Rojas R, Gómez P, Martínez F, Torres A. [Impact of initial cytomegalovirus viral load on efficacy of preemptive therapy with ganciclovir in allogeneic stem cell transplant recipients]. Enferm Infecc Microbiol Clin 2010;28:6-12. [PMID: 19409666 DOI: 10.1016/j.eimc.2009.01.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
15 Matsumura T, Narimatsu H, Kami M, Yuji K, Kusumi E, Hori A, Murashige N, Tanaka Y, Masuoka K, Wake A, Miyakoshi S, Kanda Y, Taniguchi S. Cytomegalovirus infections following umbilical cord blood transplantation using reduced intensity conditioning regimens for adult patients. Biol Blood Marrow Transplant 2007;13:577-83. [PMID: 17448917 DOI: 10.1016/j.bbmt.2006.12.454] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 3.5] [Reference Citation Analysis]
16 Liu YC, Lu PL, Hsiao HH, Chang CS, Liu TC, Yang WC, Lin SF. Cytomegalovirus infection and disease after allogeneic hematopoietic stem cell transplantation: experience in a center with a high seroprevalence of both CMV and hepatitis B virus. Ann Hematol 2012;91:587-95. [PMID: 21997849 DOI: 10.1007/s00277-011-1351-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
17 Behrendt CE, Nakamura R, Forman SJ, Zaia JA. Donor killer immunoglobulin-like receptor genes and reactivation of cytomegalovirus after HLA-matched hematopoietic stem-cell transplantation: HLA-C allotype is an essential cofactor. Front Immunol 2013;4:36. [PMID: 23440333 DOI: 10.3389/fimmu.2013.00036] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
18 Takenaka K, Nagafuji K, Takase K, Kamimura T, Mori Y, Ito Y, Nishi Y, Henzan H, Kato K, Harada N, Eto T, Miyamoto T, Teshima T, Akashi K. Initial low-dose valganciclovir as a preemptive therapy is effective for cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients. Int J Hematol 2012;96:94-100. [DOI: 10.1007/s12185-012-1087-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
19 Koehne G, Hasan A, Doubrovina E, Prockop S, Tyler E, Wasilewski G, O'Reilly RJ. Immunotherapy with Donor T Cells Sensitized with Overlapping Pentadecapeptides for Treatment of Persistent Cytomegalovirus Infection or Viremia. Biol Blood Marrow Transplant 2015;21:1663-78. [PMID: 26028505 DOI: 10.1016/j.bbmt.2015.05.015] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 7.7] [Reference Citation Analysis]
20 Giménez E, Torres I, Albert E, Piñana J, Hernández‐boluda J, Solano C, Navarro D. Cytomegalovirus ( CMV ) infection and risk of mortality in allogeneic hematopoietic stem cell transplantation (Allo‐ HSCT ): A systematic review, meta‐analysis, and meta‐regression analysis. Am J Transplant 2019;19:2479-94. [DOI: 10.1111/ajt.15515] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
21 Ong SY, Truong HT, Diong CP, Linn YC, Ho AY, Goh YT, Hwang WY. Use of Valacyclovir for the treatment of cytomegalovirus antigenemia after hematopoietic stem cell transplantation. BMC Hematol 2015;15:8. [PMID: 26090121 DOI: 10.1186/s12878-015-0028-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Yoon HS, Lee JH, Choi ES, Seo JJ, Moon HN, Kim M, Im HJ. Cytomegalovirus infection in children who underwent hematopoietic stem cell transplantation at a single center: A retrospective study of the risk factors. Pediatric Transplantation 2009;13:898-905. [DOI: 10.1111/j.1399-3046.2008.01084.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 2.6] [Reference Citation Analysis]
23 Arnaout K, Patel N, Jain M, El-Amm J, Amro F, Tabbara IA. Complications of allogeneic hematopoietic stem cell transplantation. Cancer Invest 2014;32:349-62. [PMID: 24902046 DOI: 10.3109/07357907.2014.919301] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 5.6] [Reference Citation Analysis]
24 Lin R, Liu Q. Diagnosis and treatment of viral diseases in recipients of allogeneic hematopoietic stem cell transplantation. J Hematol Oncol 2013;6:94. [PMID: 24341630 DOI: 10.1186/1756-8722-6-94] [Cited by in Crossref: 42] [Cited by in F6Publishing: 46] [Article Influence: 4.7] [Reference Citation Analysis]
25 Montesinos P, Sanz J, Cantero S, Lorenzo I, Martín G, Saavedra S, Palau J, Romero M, Montava A, Senent L, Martínez J, Jarque I, Salavert M, Córdoba J, Gómez L, Weiss S, Moscardó F, de la Rubia J, Larrea L, Sanz MA, Sanz GF. Incidence, risk factors, and outcome of cytomegalovirus infection and disease in patients receiving prophylaxis with oral valganciclovir or intravenous ganciclovir after umbilical cord blood transplantation. Biol Blood Marrow Transplant 2009;15:730-40. [PMID: 19450758 DOI: 10.1016/j.bbmt.2009.03.002] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 3.1] [Reference Citation Analysis]
26 Alam MM, Bayoumy M, Ali A, Alali M, Al-enezi B, Abosoudah I. Cytomegalovirus infection in children after bone marrow transplantation: Risk factors, clinical aspects and outcomes. Pediatric Infectious Disease 2016;8:1-7. [DOI: 10.1016/j.pid.2016.03.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
27 Wood L, Juritz J, Havemann J, Lund J, Waldmann H, Hale G, Jacobs P. Pediatric immunohematopoietic stem cell transplantation at a tertiary care center in Cape Town. Hematol Oncol Stem Cell Ther 2008;1:80-9. [PMID: 20063535 DOI: 10.1016/s1658-3876(08)50038-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
28 Torre-cisneros J, Fortún J, María Aguado J, de la Cámara R, Miguel Cisneros J, Gavaldá J, Gurguí M, Lumbreras C, Martín C, Martín-dávila P, Montejo M, Moreno A, Muñoz P, Pahissa A, Luis Pérez J, Rovira M, Bernardos Á, Gil-vernet S, Quijano Y, Rábago G, Román A, Varó E. Recomendaciones GESITRA-SEIMC y RESITRA sobre prevención y tratamiento de la infección por citomegalovirus en pacientes trasplantados. Enfermedades Infecciosas y Microbiología Clínica 2005;23:424-37. [DOI: 10.1157/13078802] [Cited by in Crossref: 49] [Cited by in F6Publishing: 34] [Article Influence: 2.9] [Reference Citation Analysis]
29 Schaenman JM, Shashidhar S, Rhee C, Wong J, Navato S, Wong RM, Ho DY, Arai S, Johnston L, Brown JM. Early CMV viremia is associated with impaired viral control following nonmyeloablative hematopoietic cell transplantation with a total lymphoid irradiation and antithymocyte globulin preparative regimen. Biol Blood Marrow Transplant 2011;17:693-702. [PMID: 20736077 DOI: 10.1016/j.bbmt.2010.08.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
30 Schmidt-Hieber M, Labopin M, Beelen D, Volin L, Ehninger G, Finke J, Socié G, Schwerdtfeger R, Kröger N, Ganser A, Niederwieser D, Polge E, Blau IW, Mohty M. CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMT. Blood 2013;122:3359-64. [PMID: 24037724 DOI: 10.1182/blood-2013-05-499830] [Cited by in Crossref: 137] [Cited by in F6Publishing: 134] [Article Influence: 15.2] [Reference Citation Analysis]
31 Asakura M, Ikegame K, Yoshihara S, Taniguchi S, Mori T, Etoh T, Takami A, Yoshida T, Fukuda T, Hatanaka K, Kanamori H, Yujiri T, Atsuta Y, Sakamaki H, Suzuki R, Ogawa H. Use of foscarnet for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation from a related donor. Int J Hematol 2010;92:351-9. [PMID: 20694532 DOI: 10.1007/s12185-010-0657-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
32 Hanisch B, Jacobsohn D, DeBiasi RL. Diagnosis and Management of Pediatric Transplant-associated Viral Infections. Pediatr Infect Dis J 2016;35:449-51. [PMID: 26766147 DOI: 10.1097/INF.0000000000001064] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
33 Kim DH, Won DI, Lee NY, Sohn SK, Baek JH, Kim JG, Suh JS, Lee KB. Survival Benefit of Asymptomatic Cytomegalovirus Reactivation after HLA-Identical Allogeneic Peripheral Blood Stem Cell Transplantation. Transplantation 2006;81:101-8. [DOI: 10.1097/01.tp.0000190102.15300.7d] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
34 Valadkhani B, Kargar M, Ashouri A, Hadjibabaie M, Gholami K, Ghavamzadeh A. The risk factors for cytomegalovirus reactivation following stem cell transplantation. J Res Pharm Pract 2016;5:63-9. [PMID: 26985438 DOI: 10.4103/2279-042X.176554] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
35 Kimura S, Wada H, Sakamoto K, Ashizawa M, Sato M, Terasako K, Nakasone H, Kikuchi M, Okuda S, Kako S, Yamazaki R, Oshima K, Tanaka Y, Tanihara A, Nishida J, Kanda Y. L-index as a novel index to evaluate both the intensity and duration of lymphopenia after allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis 2012;14:364-73. [DOI: 10.1111/j.1399-3062.2012.00727.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
36 Kimura SI, Nakamura Y, Kawamura M, Takeshita J, Kawamura S, Yoshino N, Misaki Y, Yoshimura K, Matsumi S, Gomyo A, Akahoshi Y, Tamaki M, Kusuda M, Kameda K, Wada H, Sato M, Tanihara A, Nakasone H, Kako S, Kanda Y. Association of the areas over and under the lymphocyte curve with cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis 2021;23:e13460. [PMID: 32893940 DOI: 10.1111/tid.13460] [Reference Citation Analysis]
37 Wang H, Zhu L, Xue M, Liu J, Guo Z. Low-Dose Foscarnet Preemptive Therapy for Cytomegalovirus Viremia after Haploidentical Bone Marrow Transplantation. Biology of Blood and Marrow Transplantation 2009;15:519-20. [DOI: 10.1016/j.bbmt.2008.12.510] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
38 Buyck HC, Prentice HG, Griffiths PD, Emery VC. The risk of early and late CMV DNAemia associated with Campath use in stem cell transplant recipients. Bone Marrow Transplant 2010;45:1212-9. [PMID: 19966846 DOI: 10.1038/bmt.2009.329] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
39 Gugliesi F, Coscia A, Griffante G, Galitska G, Pasquero S, Albano C, Biolatti M. Where do we Stand after Decades of Studying Human Cytomegalovirus? Microorganisms 2020;8:E685. [PMID: 32397070 DOI: 10.3390/microorganisms8050685] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
40 Chen Y, Xu LP, Liu KY, Chen H, Chen YH, Zhang XH, Wang Y, Wang FR, Han W, Wang JZ, Yan CH, Huang XJ. Risk factors for cytomegalovirus DNAemia following haploidentical stem cell transplantation and its association with host hepatitis B virus serostatus. J Clin Virol 2016;75:10-5. [PMID: 26735213 DOI: 10.1016/j.jcv.2015.12.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
41 Sutrave G, Blyth E, Gottlieb DJ. Cellular therapy for multiple pathogen infections after hematopoietic stem cell transplant. Cytotherapy 2017;19:1284-301. [DOI: 10.1016/j.jcyt.2017.07.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]